Announcements February 19, 2020; 2:30 p.m.-3:45 p.m. ET Join NCCIH and our director, Dr. Helene Langevin, as we launch NCCIHs strategic planning process for the next 5-year plan (20212026). We will kick off this year-long process with a webinar for the complementary and integrative health community on the topic of Whole Person Health. Dr. Langevin will share her thoughts on this topic, which considers the whole person and the relationships among numerous factors, including biologic, environmental, behavioral, mental, and social factors, in determining health. She will also focus on how this concept fits into and expands upon NCCIHs current strategic plan and may serve as a way to inform our strategic planning and future researchdirections. Register now. |
New animal research funded in part by the National Center for Complementary and Integrative Health (NCCIH), a component of the National Institutes of Health (NIH), suggests that stress-induced hair graying in mice may be an accessible model to investigate how stress influences tissue regeneration. This research by a multicenter team of scientists was published in a recent issue of the journalNature. | Resources for Researchers Reissue of RFA-AT-19-004 Letter of Intent Due Date(s): February 29, 2020 Application Deadline: March 30, 2020 This Funding Opportunity Announcement (FOA) encourages UG3/UH3 phased cooperative research applications to conduct efficient, large-scale pragmatic or implementation trials to improve pain management and reduce the unnecessary use of opioid medications. Awards made under this FOA will initially support a one-year, milestone-driven, planning phase (UG3), with possible transition to an implementation phase (UH3) of up to 4 years duration (5 years total for the two phases). UG3 projects that have met the scientific milestone and feasibility requirements may transition to the UH3 phase. The UG3/UH3 application must be submitted as a single application, following the instructions described in this FOA. The overall goal of this initiative is to support the "real world" assessment of health care strategies and clinical practices, and procedures in health care systems that may lead to improved pain management along with a reduction in unnecessary opioid prescribing. Results from the pragmatic trials supported by this re-issue should inform policy makers, payers, doctors and patients in the primary care, emergency department, hospital or dental setting. This FOA requires that the intervention under study be embedded into health care delivery system, real world settings. Studies can propose to integrate multi-modal or multiple interventions that have demonstrated efficacy into health care systems; or implement health care system changes to improve adherence to evidence-based guidelines. Trials should be conducted across three or more health care systems (HCS) and will become part of and work with the NIH HCS Research Collaboratory supported through the NIH Common Fund. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS. Awarded applicants will work with the HCS CCC (http://rethinkingclinicaltrials.org/about-nih-collaboratory/) to facilitate further planning and refinement of the proposed study in partnerships with health care delivery systems. March 2, 2020, 2:30 p.m.-3:30 p.m. ET NCCIH will host a technical assistance videocast onRFA-AT-20-004: HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional). This Funding Opportunity Announcement (FOA) is a reissue of previous announcementRFA-AT-19-004. The purpose of this technical assistance videocast is to provide more detail about this funding opportunity and review specific criteria. All videocast registrants will have the opportunity to submit their questions to our webinar mailbox during the videocast atNCCIHHEAL@mail.nih.gov. March 17, 2020, 2 p.m.-3 p.m. ET This Noticeis to inform potential applicants that the National Center for Complementary and Integrative Health (NCCIH), the National Institute on Aging (NIA), and the National Institute of Child Health and Human Development (NICHD) will hold a pre-application technical assistance webinar on RFA-AT-20-003, Emotional Well-Being: High-Priority Research Networks (U24, Clinical Trial Optional). The intent of this webinar is to provide an overview of the initiative and to address applicant questions prior to preparing applications. The webinar is optional and not required for application submission. Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) Notice to Extend NCCIH PAR-18-663, "Mind and Body Intervention Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)" Notice to Extend NCCIH's PAR-18-118, "NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)" Upcoming Events February 7, 2020, 10 a.m.-3:20 p.m.; Natcher Building (45), Room E1/E2, Main NIH Campus, Bethesda, MD February 7, 2020, 11 a.m.-12 p.m.; Building 40, Room 1201/1203, Main NIH Campus, Bethesda, MD In case you missed it... The NIH Office of Dietary Supplements (ODS) is offering a two and a half day educational opportunity to provide fundamental knowledge of dietary supplements to faculty, students, and practitioners with a serious interest in this subject. This intensive practicum will provide a thorough overview and grounding about issues, concepts, unknowns, and controversies about dietary supplements and supplement ingredients. It will also emphasize the importance of scientific investigations to evaluate the efficacy, safety, and value of these products for health promotion and disease prevention as well as how to carry out this type of research. The National Institute on Minority Health and Health Disparities (NIMHD) will host the Health Disparities Research Institute (HDRI) fromAugust 3-7, 2020,in Bethesda, MD.Open Application Cycle: February 3, 2020 from 9:00 a.m. ET March 9, 2020 until 5:00 p.m. ET. The HDRI aims to support the research career development of promising early-career minority health and health disparities research scientists and to stimulate research in disciplines supported by health disparities science.All applications must be submitted via the HDRI online application system by the due date; emailed applications will not be accepted. For questions or more information, emailHDRI@nih.gov. |